Sign in Subscribe

ClinRM staff

Tonlamarsen's KARDINAL Failure Reveals a Hidden Acute Care Opportunity in Severe Hypertension

Cardiology, Severe Hypertension, Clinical Trials, Tonlamarsen

Tonlamarsen's KARDINAL Failure Reveals a Hidden Acute Care Opportunity in Severe Hypertension

Deep upstream RAAS silencing demonstrates remarkable renal safety but hits definitive hemodynamic limits in chronic uncontrolled populations, requiring a strategic pivot toward inpatient acute bridging. See Disclaimer below * Introduction Acute Severe Hypertension (ASH) represents one of cardiovascular medicine's most dangerous and underserved emergencies. Affecting approximately 300,000 to

By Jitesh Rana, MD, ClinRM staff
Sutacimig in Glanzmann Thrombasthenia: From Reactive Rescue to Subcutaneous Prophylaxis

Glanzmann Thrombasthenia, Sutacimig, Hematology, Rare Diseases, Prophylaxis

Sutacimig in Glanzmann Thrombasthenia: From Reactive Rescue to Subcutaneous Prophylaxis

Phase 2 data from HMB-001-CL101 positions sutacimig as a viable prophylactic standard of care, with particular relevance for the alloimmunized subpopulation where current options have effectively run out. See Disclaimer below * Glanzmann Thrombasthenia (GT) is an ultra-rare autosomal recessive bleeding disorder caused by a genetic deficiency or dysfunction in the

By Jitesh Rana, MD, Dr. Gina Ayala, Mo Elsafy, MD MSc, Beloo Mirakhur, MD PhD, ClinRM staff
Ralinepag Demonstrates Transformative 55% Risk Reduction in PAH, Challenging Oral Selexipag Dominance

Uncategorized

Ralinepag Demonstrates Transformative 55% Risk Reduction in PAH, Challenging Oral Selexipag Dominance

Phase 3 ADVANCE OUTCOMES data establishes ralinepag as a highly potent, once-daily prostacyclin receptor agonist, delivering unparalleled functional recovery metrics despite classic pathway tolerability hurdles. See Disclaimer below * Pulmonary Arterial Hypertension (PAH) represents a progressive, highly fatal orphan disease characterized by severe right ventricular failure. The United States accounts for

By Jitesh Rana, MD, ClinRM staff